| Sivextro 200 mg powder for concentrate for solution for infusion EU/1/15/991/002-003 |
Tedizolid phosphate |
Merck Sharp & Dohme BV |
— |
| Skilarence 120 mg gastro-resistant tablets EU/1/17/1201/002-011 |
Dimethyl Fumarate |
Almirall, S.A. |
— |
| Skilarence 30 mg gastro-resistant tablets EU/1/17/1201/001 |
Dimethyl Fumarate |
Almirall, S.A. |
— |
| Skyclarys 50 mg hard capsules EU/1/23/1786/001-002 |
Omaveloxolone |
Biogen Netherlands B.V. |
— |
| Skyrizi 150 mg Solution for injection EU/1/19/1361/003 |
RISANKIZUMAB |
AbbVie Deutschland GmbH & Co. KG |
— |
| Skyrizi 150 mg Solution for injection EU/1/19/1361/002 |
RISANKIZUMAB |
AbbVie Deutschland GmbH & Co. KG |
— |
| Skyrizi 180 mg Solution for injection EU/1/19/1361/007 |
RISANKIZUMAB |
AbbVie Deutschland GmbH & Co. KG |
— |
| Skyrizi 180 mg solution for injection in pre-filled syringe EU/1/19/1361/008-009 |
RISANKIZUMAB |
AbbVie Deutschland GmbH & Co. KG |
— |
| Skyrizi 360 mg Solution for injection EU/1/19/1361/005 |
RISANKIZUMAB |
AbbVie Deutschland GmbH & Co. KG |
— |
| Skyrizi 55 mg solution for injection in pre-filled syringe EU/1/19/1361/010 |
RISANKIZUMAB |
AbbVie Deutschland GmbH & Co. KG |
— |
| Skyrizi 600 mg Concentrate for solution for injection EU/1/19/1361/004 |
RISANKIZUMAB |
AbbVie Deutschland GmbH & Co. KG |
— |
| Skyrizi 75 mg Solution for injection EU/1/19/1361/001 |
RISANKIZUMAB |
AbbVie Deutschland GmbH & Co. KG |
— |
| Skyrizi 90 mg Solution for injection EU/1/19/1361/006 |
RISANKIZUMAB |
AbbVie Deutschland GmbH & Co. KG |
— |
| Skytrofa 11 mg Powder and solvent for solution for injection EU/1/21/1607/008 |
Lonapegsomatropin, Somatropin |
Ascendis Pharma Endocrinology Division A/S |
— |
| Skytrofa 13.3 mg Powder and solvent for solution for injection EU/1/21/1607/009 |
Lonapegsomatropin, Somatropin |
Ascendis Pharma Endocrinology Division A/S |
— |
| Skytrofa 3 mg Powder and solvent for solution for injection EU/1/21/1607/001 |
Lonapegsomatropin, Somatropin |
Ascendis Pharma Endocrinology Division A/S |
— |
| Skytrofa 3.6 mg Powder and solvent for solution for injection EU/1/21/1607/002 |
Lonapegsomatropin, Somatropin |
Ascendis Pharma Endocrinology Division A/S |
— |
| Skytrofa 4.3 mg Powder and solvent for solution for injection EU/1/21/1607/003 |
Lonapegsomatropin, Somatropin |
Ascendis Pharma Endocrinology Division A/S |
— |
| Skytrofa 5.2 mg Powder and solvent for solution for injection EU/1/21/1607/004 |
Lonapegsomatropin, Somatropin |
Ascendis Pharma Endocrinology Division A/S |
— |
| Skytrofa 6.3 mg Powder and solvent for solution for injection EU/1/21/1607/005 |
Lonapegsomatropin, Somatropin |
Ascendis Pharma Endocrinology Division A/S |
— |
| Skytrofa 7.6 mg Powder and solvent for solution for injection EU/1/21/1607/006 |
Lonapegsomatropin, Somatropin |
Ascendis Pharma Endocrinology Division A/S |
— |
| Skytrofa 9.1 mg Powder and solvent for solution for injection EU/1/21/1607/007 |
Lonapegsomatropin, Somatropin |
Ascendis Pharma Endocrinology Division A/S |
— |
| Slenyto 1 mg prolonged-release tablet EU/1/18/1318/001 |
Melatonin |
RAD Neurim Pharmaceuticals EEC SARL |
— |
| Slenyto 5 mg prolonged-release tablet EU/1/18/1318/003 |
Melatonin |
RAD Neurim Pharmaceuticals EEC SARL |
— |
| SmofKabiven Central emulsion for infusion PA2059/058/002 |
Soya bean oil, refined, Medium chain triglycerides, Refined soyabean oil, Fish oil, rich in omega-3 acids, L-alanine |
Fresenius Kabi Deutschland GmbH |
Marketed |
| SmofKabiven Electrolyte Free Central emulsion for infusion PA2059/059/002 |
L-alanine, L-arginine, Glycine, L-histidine, L-isoleucine |
Fresenius Kabi Deutschland GmbH |
Marketed |
| SmofKabiven extra Nitrogen Electrolyte free, emulsion for infusion PA2059/060/002 |
Alanine, Arginine, Glycine, Histidine, Isoleucine |
Fresenius Kabi Deutschland GmbH |
Not marketed |
| SmofKabiven extra Nitrogen, emulsion for infusion PA2059/060/001 |
Methionine, Phenylalanine, Proline, Serine, Taurine |
Fresenius Kabi Deutschland GmbH |
Marketed |
| SmofKabiven Low Osmo Peripheral emulsion for infusion PA2059/022/001 |
Alanine, Arginine, Glycine, Histidine, Isoleucine |
Fresenius Kabi Deutschland GmbH |
Not marketed |
| SmofKabiven Peripheral, emulsion for infusion PA2059/061/002 |
SOYA BEAN OIL, REFINED PH. EUR., Medium chain triglycerides, Refined olive oil, Fish oil, rich in omega-3 acids, Isoleucine |
Fresenius Kabi Deutschland GmbH |
Marketed |
| SMOFlipid 200 mg/ml emulsion for infusion, excel bag PA2059/062/002 |
Soya bean oil, Medium chain triglycerides, Refined olive oil, Fish oil, rich in omega-3 acids |
Fresenius Kabi Deutschland GmbH |
Marketed |
| SMOFlipid 200 mg/ml emulsion for infusion, glass bottle PA2059/062/001 |
Soybean oil, Triglycerides, medium chain, Refined olive oil, Fish oil, rich in omega-3 acids |
Fresenius Kabi Deutschland GmbH |
Marketed |
| Sodium Chloride 0.9% w/v solution for infusion PA2059/063/003 |
Sodium chloride |
Fresenius Kabi Deutschland GmbH |
Marketed |
| Sodium Chloride 0.9% w/v Solution for Infusion PA2059/063/001 |
Sodium chloride |
Fresenius Kabi Deutschland GmbH |
Not marketed |
| Sodium Chloride 0.9% w/v Solution for Infusion PA2059/063/002 |
Sodium chloride |
Fresenius Kabi Deutschland GmbH |
Not marketed |
| Sodium Chloride 0.9% w/v Solution for Infusion PA2059/063/004 |
Sodium chloride |
Fresenius Kabi Deutschland GmbH |
Not marketed |
| Sodium Chloride 0.9% w/v Solution for Infusion, polyethylene bottle PA2059/063/005 |
Sodium chloride |
Fresenius Kabi Deutschland GmbH |
Marketed |
| Sodium chloride 0.9% w/v solvent for parenteral use PA2059/063/006 |
Sodium chloride |
Fresenius Kabi Deutschland GmbH |
Marketed |
| Sodium Nitrite Hope Pharmaceuticals 30 mg/mL Solution for Injection PA22874/001/001 |
SODIUM NITRITE |
Hope Pharmaceuticals Ltd |
Not marketed |
| Sodium Thiosulfate Hope Pharmaceuticals 250 mg/mL Solution for Injection PA22874/002/001 |
Sodium thiosulfate |
Hope Pharmaceuticals Ltd |
Not marketed |
| Sodium Valproate Seacross 100 mg/ml solution for injection/infusion PA22766/012/001 |
Sodium valproate |
Seacross Pharma (Europe) Limited |
Marketed |
| Sogroya 10 mg/1.5 mL solution for injection in pre-filled pen EU/1/20/1501/001-002 |
Somapacitan |
Novo Nordisk A/S |
— |
| Sogroya 15 mg/1.5 mL solution for injection in pre-filled pen EU/1/20/1501/005-006 |
Somapacitan |
Novo Nordisk A/S |
— |
| Sogroya 5 mg/1.5 mL solution for injection in pre-filled pen EU/1/20/1501/003-004 |
Somapacitan |
Novo Nordisk A/S |
— |
| Soliris 300 mg concentrate for solution for infusion EU/1/07/393/001 |
Eculizumab |
Alexion Europe SAS |
— |
| Solivito N powder for concentrate for solution for infusion PA2059/064/001 |
Thiamine nitrate, Riboflavin sodium phosphate, Nicotinamide, Pyridoxine hydrochloride, Sodium pantothenate |
Fresenius Kabi Deutschland GmbH |
Marketed |
| Solpa-Sinus Film-coated Tablets Paracetamol 500mg Pseudoephedrine Hydrochloride 30mg PA1186/012/001 |
Paracetamol, PSEUDOEPHEDRINE HYDROCHLORIDE |
Chefaro Ireland DAC |
Marketed |
| Soluprick SQ Timothy Grass (Phleum pratense) pollen 10 HEP Solution for skin-prick testing PA1255/005/001 |
Phleum pratense |
ALK-Abello A/S |
Marketed |
| SOMAC Control 20 mg Gastro-resistant tablet EU/1/09/516/001-004 |
Pantoprazole sodium sesquihydrate |
Takeda GmbH |
— |
| SomaKit TOC 40 micrograms kit for radiopharmaceutical preparation EU/1/16/1141/001 |
Edoteotide |
Advanced Accelerator Applications |
— |